Eisai (Thailand) Marketing Co., Ltd., (Eisai Thailand, President: Nattapan Nimmanpatcharin) announces today that it has signed a Memorandum of Understand with Thai Life Insurance Public Company Limited (Thai Life Insurance) to promote understanding, prevention, and access to the treatment of dementia including Alzheimer’s disease in Thailand.
Eisai Co., Ltd., (Eisai), notably advanced in the research and development of drugs for Alzheimer’s disease, is determined to improve the quality of life of patients, their families, and consumers, in compliance with its corporate concept of “hhc (human health care)”. In addition, Eisai is committed to the medical research and development of pharmaceutical products for early-stage Alzheimer’s disease patients for a better quality of life as well as to the equal access opportunity to medical care.
Based on hhc corporate concept, Eisai Thailand, a subsidiary of Eisai in Thailand, has been working to drive the awareness of the public in caring for the elderly and those who are suffering from this disease, through its various recognition programs like Social Media Awareness and the other aid programs such as brain health assessment tool.
During the signing ceremony, Mr. Shohei Kanazawa, Vice President, President of Asia and Latin America Region of Eisai said “Spending time with patients to understand their true needs through “empathy”, based on Eisai’s corporate concept has become the source of innovation. In addition, Eisai has been at the forefront of Alzheimer’s disease research and development for over 35 years.
Alzheimer’s disease is a growing threat for patients and their families in Thailand considering the rising care costs and the requirement for long-term care. The world is approaching an era of early detection and diagnosis of Alzheimer’s disease and simultaneously Eisai is transforming itself from a pharmaceutical company to a health-care ecosystem company, in alliance with partners such as Thai Life Insurance, to provide multi-modal solutions and innovations to the people. In consequence, the collaboration with Thai Life Insurance is a crucial step towards Eisai’s mission of providing better health care options and innovations to people in Thailand for a better quality of life based on the company’s corporate concept of hhc for the world.”
Mr. Chai Chaiyawan, Director& Chief Executive Officer of Thai Life Insurance discloses that the aim of the company is to meet every expectation that life insurance, health insurance, and life solutions provider have to offer, by virtue of good health and happy life of the insured and the public, including particularly the eco-health system, which promotes both preventive and curative health care.
The Thai population is aging rapidly. One of the common complications among the elderly people is dementia including Alzheimer’s disease, which has become a threat to patients and their families. Considering the prevailing number of older Thais, the number of dementia cases is projected to rise from current 600,000 to 1.1 million by 20301.
In Thailand, care cost is rising especially in cases of chronic diseases. This is also the case for Alzheimer’s disease in which patients require long-term support that can affect the quality of life of their families as well. The recent technological and the medical advancements are expected to improve the quality of life for early-stage Alzheimer’s disease patients. Nevertheless, the burden of and the access issue to dementia treatment at this early stage can be expected, which may affect one’s payment ability and financial resources of the individual and his or her family by long term care of dementia.
To improve the quality of life of the insured and all Thai people, Thai Life Insurance and Eisai Thailand have consequently concluded a collaboration agreement to promote understanding and prevention of dementia in Thailand. As the first step, Thai Life Insurance and Eisai Thailand will work together to raise awareness and improve perception of dementia and brain health. Both companies will ultimately develop an effective ecosystem related to Alzheimer’s disease in collaboration with related stakeholders which promote products and services for better quality of life of the patients and their families in long-term.
As a part of our initiatives, life and health care insurance products will be developed to cover dementia including Alzheimer’s disease for the ultimate medical care access and option. This includes extension of the insurance coverage of its established products, e.g. critical illness coverage to include particularly the early-stage patients with Alzheimer’s disease.
The two companies will collaborate to provide better quality of life to Alzheimer’s disease patients and their families in Thailand.
